Trump's generic drug tariff plan raises questions over prices, U.S. manufacturing and which drugmakers stand to gain or lose ...

Most generic drugs are made overseas — which can cause problems for U.S. consumers. But this tariff might not be a cost-effective solution for Americans.

The administration timed a new set of tariffs on all of its largest trading partners to take effect at the same time the old, ...